They can help with chronic pain, skin rejuvenation , and athletic recovery
Introduction Tertiary lymphoid structures (TLS, also known as tertiary lymphoid tissues, tertiary lymphoid organs, or ectopic lymphoid tissues) are ectopic lymphoid structures that are induced in nonlymphoid organs by several stimuli, including autoimmunity, infection, and aging
#MASLD #FungalSensing To view or add a comment, sign in Its #PublicationSunday featuring research using the Advion Interchim Scientific expression Compact Mass Spectrometer (CMS)
If you experience any adverse effects, reduce the frequency or consult a dermatologist
Key Takeaways Cagrilintide is a long-acting amylin analogue with clinical trial doses ranging from 0.3 mg to 4.5 mg weekly, while retatrutide is a triple agonist studied at 4 mg, 8 mg, and 12 mg weekly doses No published clinical trials currently exist evaluating the cagrilintide dosage with retatrutide combination, making any combined use experimental and off-label Both peptides work through different mechanismscagrilintide activates amylin receptors while retatrutide targets GIP, GLP-1, and glucagon receptorssuggesting potential complementary effects Gastrointestinal side effects (nausea, vomiting) occur in 60-80% of participants at higher doses for both compounds, raising concerns about additive effects when combined Proper dose escalation protocols spanning 8-20 weeks are critical for tolerability and adherence in peptide-based metabolic therapies Understanding Cagrilintide: Mechanism and Dosage Fundamentals What Is Cagrilintide
